HYPOXIA-ACTIVATED ANTI-CANCER AGENTS

摘要

Prodrugs of cyclic anthracyclin toxins comprising a hypoxia-activated trigger and are disclosed. In addition, methods of treating cancer using the compounds of the invention are disclosed.